GB2359746A - Antibacterial agents - Google Patents
Antibacterial agents Download PDFInfo
- Publication number
- GB2359746A GB2359746A GB0000187A GB0000187A GB2359746A GB 2359746 A GB2359746 A GB 2359746A GB 0000187 A GB0000187 A GB 0000187A GB 0000187 A GB0000187 A GB 0000187A GB 2359746 A GB2359746 A GB 2359746A
- Authority
- GB
- United Kingdom
- Prior art keywords
- composition
- oil
- oral
- weight
- dough
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003242 anti bacterial agent Substances 0.000 title description 5
- 239000000203 mixture Substances 0.000 claims description 51
- 239000000341 volatile oil Substances 0.000 claims description 35
- 235000013305 food Nutrition 0.000 claims description 29
- 238000000034 method Methods 0.000 claims description 27
- 241001465754 Metazoa Species 0.000 claims description 19
- 210000000214 mouth Anatomy 0.000 claims description 19
- 239000003921 oil Substances 0.000 claims description 16
- 235000019198 oils Nutrition 0.000 claims description 16
- 238000004519 manufacturing process Methods 0.000 claims description 14
- 235000007129 Cuminum cyminum Nutrition 0.000 claims description 11
- 230000005764 inhibitory process Effects 0.000 claims description 9
- 241001148471 unidentified anaerobic bacterium Species 0.000 claims description 9
- 240000000662 Anethum graveolens Species 0.000 claims description 8
- 206010006326 Breath odour Diseases 0.000 claims description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 8
- 239000001525 mentha piperita l. herb oil Substances 0.000 claims description 8
- 235000019477 peppermint oil Nutrition 0.000 claims description 8
- 244000052616 bacterial pathogen Species 0.000 claims description 7
- 208000028169 periodontal disease Diseases 0.000 claims description 7
- 239000001941 cymbopogon citratus dc and cymbopogon flexuosus oil Substances 0.000 claims description 6
- 208000007565 gingivitis Diseases 0.000 claims description 6
- 238000011282 treatment Methods 0.000 claims description 6
- 208000032139 Halitosis Diseases 0.000 claims description 5
- 208000035475 disorder Diseases 0.000 claims description 5
- 244000018436 Coriandrum sativum Species 0.000 claims description 4
- 235000002787 Coriandrum sativum Nutrition 0.000 claims description 4
- 240000004784 Cymbopogon citratus Species 0.000 claims description 4
- 235000017897 Cymbopogon citratus Nutrition 0.000 claims description 4
- 208000002925 dental caries Diseases 0.000 claims description 4
- 230000036541 health Effects 0.000 claims description 3
- 238000012423 maintenance Methods 0.000 claims description 2
- 244000304337 Cuminum cyminum Species 0.000 claims 3
- 235000015895 biscuits Nutrition 0.000 description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 28
- 241000282472 Canis lupus familiaris Species 0.000 description 17
- 239000000463 material Substances 0.000 description 16
- 230000000694 effects Effects 0.000 description 15
- 239000000047 product Substances 0.000 description 15
- 241000282412 Homo Species 0.000 description 11
- 230000000844 anti-bacterial effect Effects 0.000 description 10
- 235000019197 fats Nutrition 0.000 description 10
- 239000003981 vehicle Substances 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical group CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 9
- 239000003906 humectant Substances 0.000 description 9
- 235000012054 meals Nutrition 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 8
- 241000510672 Cuminum Species 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 241000124008 Mammalia Species 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 230000000845 anti-microbial effect Effects 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 235000013372 meat Nutrition 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- 241000209140 Triticum Species 0.000 description 5
- 235000021307 Triticum Nutrition 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- -1 alkylene glycol Chemical compound 0.000 description 5
- 239000000551 dentifrice Substances 0.000 description 5
- 239000003349 gelling agent Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 238000005498 polishing Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 241000282465 Canis Species 0.000 description 4
- 239000011149 active material Substances 0.000 description 4
- 239000010636 coriander oil Substances 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 235000013312 flour Nutrition 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 239000000606 toothpaste Substances 0.000 description 4
- 235000019737 Animal fat Nutrition 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- 208000002064 Dental Plaque Diseases 0.000 description 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 3
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 3
- 230000002882 anti-plaque Effects 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 235000015111 chews Nutrition 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 238000000465 moulding Methods 0.000 description 3
- 239000002324 mouth wash Substances 0.000 description 3
- 239000004006 olive oil Substances 0.000 description 3
- 201000001245 periodontitis Diseases 0.000 description 3
- 235000013772 propylene glycol Nutrition 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 239000002600 sunflower oil Substances 0.000 description 3
- 229940034610 toothpaste Drugs 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 240000004160 Capsicum annuum Species 0.000 description 2
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 2
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- 244000020551 Helianthus annuus Species 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 235000019735 Meat-and-bone meal Nutrition 0.000 description 2
- 235000011203 Origanum Nutrition 0.000 description 2
- 240000000783 Origanum majorana Species 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 235000019764 Soybean Meal Nutrition 0.000 description 2
- 235000019486 Sunflower oil Nutrition 0.000 description 2
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 241001148470 aerobic bacillus Species 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000001680 brushing effect Effects 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 229940095710 chewable product Drugs 0.000 description 2
- 229940112822 chewing gum Drugs 0.000 description 2
- 235000015218 chewing gum Nutrition 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000005802 health problem Effects 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 239000008375 oral care agent Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000004455 soybean meal Substances 0.000 description 2
- 238000001256 steam distillation Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- JLPAMKUIIFHLBH-UHFFFAOYSA-N 1,2-dihydroxypropane-1-sulfonic acid Chemical compound CC(O)C(O)S(O)(=O)=O JLPAMKUIIFHLBH-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- TYBHZVUFOINFDV-UHFFFAOYSA-N 2-bromo-6-[(3-bromo-5-chloro-2-hydroxyphenyl)methyl]-4-chlorophenol Chemical compound OC1=C(Br)C=C(Cl)C=C1CC1=CC(Cl)=CC(Br)=C1O TYBHZVUFOINFDV-UHFFFAOYSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 239000004150 EU approved colour Substances 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 244000061408 Eugenia caryophyllata Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 241000605909 Fusobacterium Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000212322 Levisticum officinale Species 0.000 description 1
- 241000191992 Peptostreptococcus Species 0.000 description 1
- 240000009164 Petroselinum crispum Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000605894 Porphyromonas Species 0.000 description 1
- 241000605861 Prevotella Species 0.000 description 1
- 241001135261 Prevotella oralis Species 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical class [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 241001148134 Veillonella Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000008055 alkyl aryl sulfonates Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229910021502 aluminium hydroxide Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000002272 anti-calculus Effects 0.000 description 1
- 230000001857 anti-mycotic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000002543 antimycotic Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000019568 aromas Nutrition 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 229940036811 bone meal Drugs 0.000 description 1
- 239000002374 bone meal Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 229920003064 carboxyethyl cellulose Polymers 0.000 description 1
- 229920003090 carboxymethyl hydroxyethyl cellulose Polymers 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004075 cariostatic agent Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000012050 conventional carrier Substances 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 239000008162 cooking oil Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229940091249 fluoride supplement Drugs 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 210000003731 gingival crevicular fluid Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 239000001645 levisticum officinale Substances 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 230000007269 microbial metabolism Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- MPQXHAGKBWFSNV-UHFFFAOYSA-N oxidophosphanium Chemical group [PH3]=O MPQXHAGKBWFSNV-UHFFFAOYSA-N 0.000 description 1
- 235000011197 perejil Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 238000000197 pyrolysis Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 229960000414 sodium fluoride Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 1
- 229960002799 stannous fluoride Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- GFQYVLUOOAAOGM-UHFFFAOYSA-N zirconium(iv) silicate Chemical compound [Zr+4].[O-][Si]([O-])([O-])[O-] GFQYVLUOOAAOGM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Oral & Maxillofacial Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Fodder In General (AREA)
Description
Chemical <U>Compositions II</U> The present invention is concerned with the use of essential oils as antibacterial agents. The present invention is particularly concerned with the use of such oils in the treatment of oral health problems in humans and animals, particularly domestic animals.
It has been suggested that periodontal disease is the single most common disease encountered in small animal veterinary practice. The path to periodontal disease, both in humans and in companion animals, begins with the accumulation of deposits of plaque. Dental plaque is a soft, gelatinous material which forms on a tooth surface and is composed of bacteria and their metabolic by-products, saliva components, food debris and occasional cells from the gums. Plaque deposits are the first step in the development of gingivitis and as such are a significant factor in oral health. Gingivitis is an inflammation of the gums, produced essentially by the body's immune response to the bacteria in dental plaque. Gingivitis sometimes, although not always, leads to the development of periodontal disease.
Halitosis (bad breath or oral malodour) is a common problem both in domestic pets and in humans. Current thinking suggests that the predominant source of bad breath is the mouth. This is supported by experimental findings which show that oral hygiene procedures such as tooth brushing markedly decrease malodour, while conditions such as dental caries and periodontitis increase the incidence and intensity of oral malodour [G.F. Sulser, <I>et al. J.</I> Dental Research, 18: 355-359 (1939)]. Oral malodour is produced as a result of microbial metabolism of exogenous and endogenous proteinaceous substrates. No single micro organism has been indicated as the primary cause. The proteinaceous substrates can be derived from food debris, exfoliated oral epithelium, saliva, blood and gingival crevicular fluid. The proteins obtained from these sources undergo proteolysis to peptides and amino acids which are further metabolised to highly volatile compounds. It is these volatile compounds which are perceived as oral malodour. It has been shown that the predominant unpleasant-smelling components of bad breath are volatile sulphur compounds or VSCs [J. Tonzetich, J. Periodontology, 48: 13-20 (1977)], the most significant being hydrogen sulphide (112S) and methyl mercaptan (CH3SH). The determination of the levels of VSCs can provide a quantitative measure of the extent of oral malodour and can be used in the evaluation of treatments for reducing oral malodour.
It has been suggested that very many species of bacteria may inhabit the oral cavity, but a subset of these species, most of which are gram negative, anaerobic bacteria, are strongly implicated in periodontitis, oral malodour production and other associated oral health problems (Oral Microbiology, Std Edition, P. Marsh and M. Martin (eds), 1992, London, Chapman & Hall). McNamara<I>et al.</I> ("The role of microorganisms in the production of oral malodor", Oral Surg, 34(1): 4l-48, 1972) proposed that intrinsic oral malodour is readily produced by gram negative micro-organisms in localised areas within the mouth, such as the gingival crevice, interdental spaces, dental plaque, tonsillar folds and papillary crypts of the tongue, where saliva stagnation commonly occurs. It has also been shown that <I>Streptococcus</I> salivarius, an aerobic bacteria species, is associated with the functioning of healthy mouths.
It is well known that essential oils have antimicrobial properties and there are many commercial products which exploit these properties, including mouthwashes, shampoos and antiseptic creams. Fornell J.<I>et al.</I> (Scand. J. Dent. Res.<B>1975,</B> 83, 18-25), for example, disclose the plaque-controlling properties of an antiseptic mouthwash comprising thyme and eucalyptus oils. US-5472684 discloses an antibacterial oral composition for countering plaque and gingivitis comprising thymol and eugenol.
Deans S.G. and Ritchie G. (Int. J. Food Microbiol., 1987, 5, 165-180) examined the antibacterial properties of fifty essential oils against twenty-five genera of bacteria. In this study, the most comprehensive antibacterial properties where shown by Angelica, Bay, Cinnamon, Clove, Thyme, Bitter Almond, Marjoram, Pimento, Geranium and Lovage essential oils. However, amongst the 25 bacteria species used in that study, 24 were aerobic. Of the essential oils tested, only Angelica, Laurel, Marjoram, Parsley, Pimento, Rosemary and St John's Wort were reported as having any effect on the anaerobic species. The antimicrobial activity of various essential oils has also been documented by Morris, J.A. <I>et al.</I> (J. Am. Oil Chem. Soc. 1979, 56, 595-603). In that study, essential oils such as clove and lemongrass oils demonstrated good antibacterial activity against aerobic bacteria. Further investigations on the antimicrobial activity of various essential oils were conducted by Youssef R.T. and Tawil G.G. (Pharmazie 35, H.<B>11</B> 1980) and by Balchin <I>et</I> <I>al.</I> (Flavour and Fragrance Journal, 13, 98-104, 1998; and J. Herbs, Spices & Med. Plants, 4(2),<B>69-86,1996).</B>
It is an object of this invention to provide an antibacterial agent which exhibits antibacterial activity against pathogenic bacteria present in the oral cavity of humans and other mammals. It is a further object of this invention to provide an antibacterial agent which exhibits antibacterial activity against anaerobic bacteria present in the oral cavity of humans and other mammals. It is a further object of this invention to provide an antibacterial agent which exhibits antibacterial activity against gram negative, anaerobic bacteria present in the oral cavity of humans and other mammals.
It has now been found that certain essential oils, which in earlier studies had previously demonstrated only weak antibacterial activity, are particularly potent in their antibacterial effect against species of bacteria which are strongly implicated in periodontal disease and/or malodour production.
According to the present invention there is provided the use of an effective amount of one or more essential oils selected from coriander oil, cumin oil, dill weed oil, lemongrass oil and peppermint oil in the manufacture of a composition for the inhibition of pathogenic bacteria, particularly anaerobic bacteria, present in the oral cavity of humans and other mammals, the composition being suitable for oral administration.
According to a further aspect of the invention there is provided a method of inhibition of pathogenic bacteria, particularly anaerobic bacteria, present in the oral cavity of humans and other mammals, by the oral administration to a subject in need thereof of a composition comprising an effective amount of one or more essential oil(s) selected from coriander, cumin, dill weed, lemongrass and peppermint oils.
The use or method of the present invention is directed to the maintenance of oral health. The use or method may be used in the treatment of halitosis or disorders associated with the oral cavity, particularly such disorders which are related to or substantially caused by the activity of anaerobic bacteria.
As used herein, the term "disorders associated with the oral cavity" refers to gingivitis, periodontal disease and dental caries.
The use or method of the present invention is intended for use in both humans and animals, particularly domestic animals.
An essential oil is the volatile ethereal fraction obtained from a plant or plant part by a physical separation method. The physical separation method usually involves either distillation (including water distillation, steam distillation, water and steam distillation and dry distillation) or expression (pressing). Enfleurage, a process in which a floral material is adsorbed onto fat and the essential oil obtained by alcoholic extraction from this fat, may also be used to obtain the essential oil. Generally, essential oils represent the odorous part of the plant material.
The essential oils are either available commercially or may be obtained from the plant or plant part by conventional separation techniques, as described above.
In one embodiment, the composition comprises at least about 5 ppm, preferably at least about 50 ppm, preferably at least about 100 ppm, more preferably at least about 150 ppm and more preferably at least about 200 ppm by weight of the composition of the or each essential oil. It is preferred that the composition comprises no more than about 20000 ppm, preferably no more than about 10000 ppm, preferably no more than about 5000 ppm, preferably no more that about 2000 ppm, preferably no more that about<B>1000</B> ppm, and preferably no more than about 500 ppm by weight of the composition of the or each essential oil.
In general, compositions for animal use contain a smaller amount of active ingredient in relation to compositions for human use. If too great an amount of active ingredient is added, the composition becomes unpalatable for the animal. Preferably, compositions for animal use contain no more than about 2000 ppm, preferably no more than about<B>1000</B> ppm, and preferably no more than about 500 ppm by weight of the composition of the or each essential oil.
According to a further aspect of the invention, there is provided a composition for the inhibition of pathogenic bacteria, particularly anaerobic bacteria, present in the oral cavity of humans and other mammals, the composition being suitable for oral administration and comprising an effective amount of one or more essential oil(s) selected from cumin oil, coriander oil, dill weed oil, lemongrass oil and peppermint oil.
According to a further aspect of the invention there is provided a process for the production of a composition for the inhibition of pathogenic bacteria, particularly anaerobic bacteria, present in the oral cavity of humans and other mammals, the composition being suitable for oral administration, as herein described, the process comprising the steps of admixing an effective amount of one or more essential oil(s) selected from cumin oil, coriander oil, dill weed oil, lemongrass oil and peppermint oil with one or more conventional and acceptable carriers or excipients. In an alternative embodiment, such as the embodiment relating to chewable animal products described below, the one or more essential oil(s) selected from cumin oil, coriander oil, dill weed oil, lemongrass oil and peppermint oil are applied to the surface of a conventional carrier composition such as a rawhide strip.
Suitable formulations for the use and method of treatment of the present invention will now be described for animal and human subjects.
In the aspect of the invention which is directed to the use or method described herein in relation to animals, particularly domestic animals, the compositions can be any of the conventional animal food types known in the art, including dry pet foods such as pelletized dog or cat foods or main meals, etc. Alternatively, the active ingredient(s) may be incorporated into a composition which is a chewable product or toy, such as a chewable plastic product or toy, or a rawhide chew.
It is preferred that a pet food composition is a dry or semi-moist pet food, preferably a biscuit. In addition to the essential oil(s), the compositions may comprise ingredients and additives similar to those used in conventional pet foods. The essential oil(s) may be added to the pet food composition at any stage of its manufacture. The pet food compositions may be made according to conventional methods well-known to those skilled in the art. The manufacture of dry and semi-moist pet foods and particularly pet biscuits generally involves the step of shaping and baking a dough containing the desired ingredients. The dough can be any suitable dough known in the art. The essential oil(s) are generally added to the dough before baking and, accordingly, if the essential oil is volatile the dough should contain a higher concentration of essential oil than is desired in the final biscuit. Typically, the dough should contain the essential oil(s) in an amount which is between 2 and 10 times greater than that required in the final biscuit. The precise amount of essential oil(s) added to the dough will depend,<I>inter</I> alia, on the temperature and duration of heating, on the size of the biscuit and on the volatility of the plant extract(s) used.
In one embodiment, the term "dry pet food" as used herein is intended to mean a pet food having a water activity A, of less than 0.65. In this embodiment, the term "semi-moist pet food" as used herein is intended to mean a pet food having a water activity A, of from about 0.65 to about 0.86. Water activity is a measure of the relative humidity above a sample of the pet food. The relative humidity is measured above a sample in a sealed chamber after being allowed to equilibrate. A device which is suitable for measuring these parameters is the Rotronic Hygroskop DT T ". The water activity is on a scale of 0 to 1.0 and is defined as: water activity AW = 1/loo (relative humidity) The water activity reflects the amount of water which is available to micro-organisms for growth and multiplication. At a water activity of less than 0.65, it is. not usually necessary to add preservatives to the pet food. At a water activity of from about 0.65 to about 0.86, it is desirable to add preservatives to the pet food to prevent the growth of mould although the growth of bacteria is minimal under such conditions.
The water content that corresponds to the water activities defined above can vary considerably depending upon a number of factors, such as the presence and levels of humectants (such as salt, sugar or glycerol etc) in the pet food. Typically, however, a "dry pet food" has a water content of less than about 15% by weight of the final biscuit and a "semi-moist pet food" has a water content of from about 15% to about 25% by weight of the final biscuit. Thus, in an alternative embodiment, the term "dry pet food" as used herein means a pet food which has a water content of less than about 15%, preferably less than about 14%, by weight of the final biscuit. In this alternative embodiment, the term "semi-moist pet food" as used herein means a pet food which has a water content of from about 15% to 25%, preferably from about 14% to about 25%, by weight of the final biscuit.
The preparation of dog biscuits will now be described in detail.
The dog biscuits . can be made from conventional dog biscuit doughs. The dough can comprise at least one flour, meal, fat and water. A conventional dough for dog biscuits may also contain discrete particles of meat and/or meat byproducts or farinaceous material. Such doughs typically contain fat solids. Examples of suitable doughs for the production of hard dog biscuits are disclosed in U.S. Patent Nos. 4,454,163 and 4,743,459, and suitable doughs for the production of soft dog biscuits (containing humectant to control water activity) are disclosed in U.S. Patent No. 4,454,164. The disclosures of such doughs and the manufacture of pet food disclosed in U.S. Patent Nos. 4,454,163, 4,454,164 and 4,743,459 are incorporated herein by reference. Particulate proteinaceous particles, such as particles of meat, texturized vegetable protein and/or meat byproducts, can be incorporated to add flavour to the biscuits and texturize the surface. (See U.S. Patent 4,743,459, for example.) Particular farinaceous materials, such as bran particles, can also be employed to texturize the interior and/or surface or the biscuits and to provide other useful properties to the product. A dough found to produce biscuits highly palatable to dogs includes suitable proportions of wheat flour, wheat meal, soybean meal, meat and bone meal, animal fat and natural flavours in admixture with water. The meal used in the doughs suitable for production of biscuits of the invention can comprise meat and/or bone and/or vegetable matter including farinaceous materials, materials prepared from legumes such as beans and peas, tuberous materials such as potato meal, and the like. The meals can be finely or coarsely ground as desired for the texture. Flours made from any suitable farinaceous material can be used. A suitable dough contains farinaceous material, an edible oil, an antioxidant, an antimycotic, salt, animal fat added vitamins and minerals, such as those disclosed in U.S. Patent No. 4,229,485, column 5, lines 7 to 57, which is incorporated herein by reference. The compositions of the invention may also contain at least one animal-derived proteinaceous meal such as meat meal, bone meal or fish meal. A good biscuit dough for producing the biscuits of the invention contains about 50 to 60 percent by weight of wheat flour, about 5 to 10 percent by weight of soybean meal, about 3 to 10 percent by weight of meat and bone meal, about 1 to 5 percent of wheat meal, about 1 to 5 percent of animal fat preserved with BHA, about 20 to 30 percent by weight of water, about 2 to 5 percent by weight of natural flavours, vitamin and mineral preblend, and acidulant.
The dough ingredients are generally admixed at a temperature of about 5 to about 60 C, preferably about 15 C to about 30 C.
The dog biscuit doughs can contain a softening agent or humectant. The preferred humectant is propylene glycol. Examples of other humectants which can be used are corn syrup, sugar and polyalcohols, such as sorbitol and glycerin.
The dough can also contain edible surfactants or emulsifying agents, e.g. cationic agents and nonionic agents. Exemplary nonionic emulsifying agents can be broadly defined as compounds produced by the condensation of alkylene oxide groups (hydrophilic in nature) with an organic hydrophobic compound which can be aliphatic, alkyl aromatic, or a condensate of an alkylene oxide with an alkylene glycol (hydrophilic in nature). Examples of nonionic emulsifying agents which can be used include polyethylene oxide condensates of alkyl phenols, products derived from the condensation of ethylene oxide with the reaction product of propylene oxide and ethylene diamine, ethylene oxide condensates of aliphatic alcohols, long chain tertiary amine oxides, long chain tertiary phosphine oxides, long chain dialkyl sulfoxides and mixture of such materials. The emulsifier is generally used in minor amounts.
The dog biscuit dough can be mixed using conventional equipment. For example, the mixing can be at 20 to 100 rpm. For example, a dry blending step can be done at room temperature for a period of time of about 3 minutes to about 20 minutes. The dry-blended mixture can then be mixed with water to form a first stage dough. The water which can be admixed with the dryblended mixture is typically at a temperature of about 20 C to about 65 C. The water can be added, with mixing, over a period of time of about 3 minutes to about 6 minutes to form the first stage dough. Then, the fat portion of the biscuit dough can be admixed with the first stage dough to form the final stage dough. The fat portion can be added at a temperature at which it is at least fluid, typically at about 35 C to about 65 C. The fat portion can be mixed for a period of time which is sufficient to form a dough whose homogeneity is visually apparent. A typical final mixing time is about 3 to about 5 minutes.
Formation of the dough is achieved at about atmospheric pressure with the mixing of the components being conveniently achieved in an upright sigma blade mixer or other bakery- type mixers. The various ingredients can be added over a period of time or in a one-shot process according to the above order of addition. However, melted fat and water can be added simultaneously and mixed for about 6 to 10 minutes.
The dog biscuits are formed in any conventional or suitable manner, such as by extrusion, stamping, cutting or molding. Any suitable dog biscuit shape, such as a bone-shaped biscuit, can be used. For many products, such as the bone-shaped canine biscuits of the invention, a rotary molding system is preferred because it permits the rapid forming of dough pieces with good control over their shape, form and surface characteristics. Docker holes are optionally formed in the dough piece during molding to facilitate the escape of moisture during baking, cooking and/or drying.
The dough is formed into pieces by machining on a rotary molder with specific die shapes. The dough can also be formed into pieces by sheeting followed by either a vertical or rotary cutter or by a rotary molder. Suitable die and cutter shapes are those which result in biscuit products having bone, round, square, triangular, T-bone or chop shapes and the like. The forming is achieved at conventional temperatures of ambient to about 45 C and pressures of less than about 5% kg/cm2, used with a rotary molder, a vertical cutter or rotary cutter. The dough pieces can be baked using any suitable or conventional equipment and conditions. For example, the dough pieces can be passed into a conventional oven where the biscuit is baked. The conveyer belts of the oven can be coated with an edible lubricant, such as a natural or synthetic cooking oil or shortening, to facilitate separation of the conveyer belts of the baked product. Temperatures in the range of about 100 C to about 300 C can be used. The baked biscuits can also be subjected to subsequent drying at temperatures of about 90 C to 200 C either within the baking oven or separately, to produce the desired moisture content in the final product. Baking and drying temperatures and times are those conventionally used in the production of a canine biscuit. Typically, baking temperatures and times for a hard, dry canine biscuit are about 100 C to about 250 C for about 25 minutes to about 8 minutes. Drying conditions for a hard, dry canine biscuit are typically about 90 C to about 160 C for about 25 minutes to about 12 minutes in a forced air dryer. On a weight basis, the moisture content of the final dry biscuit is preferably less than or equal to about 15 percent by weight and preferably about 10 to 12 percent by weight of the final biscuit at 70 percent relative humidity.
The baking and drying process provides a shelf stable product without the need of any moisture barrier protection.
The pet food composition is particularly of use for dogs. For an average biscuit weight of 10 grams, a recommended maximum biscuit intake is about 10 biscuits a day for a medium size dog, which should supply, for example, about 1/4 of the daily calorific requirement of a 25 kg dog.
Chewable products and rawhide chews are well-known in the art. For instance, EP-A- 0272968 discloses a chewable product for dogs and other domestic animals wherein aqueous solutions of oral care agents, such as sodium flouride (an anti-caries agent), sodium benzoate (an anti-calculus agent) and bromochlorophene (an anti-microbial/anti- plaque agent), are used to soak rawhide, beef tendon or ligament. The solution-treated product is then dried and the oral care agents are absorbed into the surface of the product. The disclosure of EP-A-0272968 relating to the manufacturing process for chewable products, particularly rawhide chews, is incorporated herein by reference. Other animal chew products are disclosed in US-5405836 and EP-A-0552897. A rawhide chew for use in the present invention may be any of those commercially available or may be made according to any of the processes known in the art. Usually, rawhide chews are elongated strips of treated rawhide, which may be knotted, although any shape of rawhide chew may be used in the present invention. The active ingredients may be applied topically to the rawhide, for example by spraying or dipping, using an aqueous solution. Conventional spraying or dipping equipment may be used. The aqueous solution may contain a fat, such as tallow, which may improve the adhesion of the solution and active ingredient to the chew. The fat content of the solution may, for example, be up to 10 by weight, preferably from about 0.2 to about 3 % by weight. The animal may chew from 1 to about 3 pieces of rawhide chew per day to achieve the desirable antibacterial effects described herein.
With regard to human subjects, the compositions may be incorporated into oral formulations in general, such as mouthrinses, toothpastes, lozenges, confectionery, chewing gum or dental floss, containing a dental vehicle.
The dental vehicle contains liquids and solids in a dentifrice. In general, the liquid comprises water and/or a humectant, such as glycerine, sorbitol, polyethylene glycol or propylene glycol including suitable mixtures thereof. It is usually advantageous to use a mixture of both water and one or more humectants. The total liquid content is generally about 5-90 percent by weight of the vehicle. In transparent and translucent vehicles, the liquid content of a toothpaste may be about 5-90 percent by weight, while in opaque vehicles the total liquid content is usually about 5-50 percent by weight. Preferred humectants are glycerine, sorbitol, and polyethylene glycol.
The solid portion of the vehicle is a gelling agent. In the instant invention, the gelling agent includes alkali metal carboxymethyl cellulose, hydroxyethyl cellulose and hydroxymethyl cellulose in an amount of at least about 0.5 percent by weight of the vehicle. Additional gelling agents may also be present. Gelling agents which may be additionally present include xanthan gum, viscarin, gelatin, starch, glucose, sucrose, polyvinyl pyrrolidone, polyvinyl alcohol, gum tragacanth, gum karaya, hydroxypropyl cellulose, methyl cellulose, carboxyethyl cellulose (CMC) and sodium alginate. The solid portion or gelling agent of the vehicle is typically present in an amount of about 0.5-5.0 percent by weight of the toothpaste and preferably about 0.5-2.0 percent by weight.
Any suitable substantially water-insoluble polishing agent may be added to the gel vehicle of the dentifrice. There is a relatively large number of such materials known in the art. Representative materials include, for example, dicalcium phosphate, tricalcium phosphate, aluminium hydroxide, magnesium carbonate, calcium carbonate, calcium pyrophosphate, calcium sulfate, bentonite, alumina, hydrated alumina, aluminum silicate, zirconium silicate and silica, including mixtures thereof.
Water-soluble polishing agents, such as sodium bicarbonate can also be used. When sodium bicarbonate is present, plaque and caries reduction is generally improved.
In general these polishing agents will comprise a major proportion by weight of the solid ingredients. The polishing agent content is variable but will generally be up to about 75 percent by weight of the total composition, preferably about 20-75 percent, although even lower amounts of polishing agent can be employed, for instance about 10% or more of sodium bicarbonate.
Any suitable surface-active material may be incorporated into the gel vehicle. Such compatible materials are desirable to provide detersive and foaming properties depending upon the specific type of surface-active material selected. These detergents are water- soluble organic compounds for the most part and may be anionic, cationic or non-ionic in structure. It is preferred to use the water-soluble non-soap or synthetic organic detergents. Suitable detersive materials are known and include the water-soluble anionic salts of higher fatty acid monoglyceride monosulfate detergents (e.g., sodium coconut fatty acid monoglyceride monosulfate), higher alkyl sulfates (e.g., sodium lauryl sulfate), alkyl aryl sulfonates (e.g., sodium dodecyl benzene sulfonate), higher fatty acid esters of 1,2 dihydroxypropane sulfonate, and the like. Other suitable surface-active materials include non-ionic surface-active agents, such as condensates of ethylene oxide with propylene oxide condensates of propylene glycol. The various surface-active materials may be used in any suitable amount, generally from about 0.05 to about 10 percent by weight, and preferably from about 0.5 to about 5 percent by weight of the dentifrice composition.
The compositions may also contain antiplaque activity boosters in minimal amounts up to about 5 percent by weight, such as polyvinyl malefic acid/maleic anhydride copolymer or polyvinyl phosphonate which deposits on tooth surfaces and inhibits plaque adhesion onto the surface. The essential oils work by a different mechanism; as antimicrobials they inhibit bacterial reproduction and hence plaque growth. Therefore, the two different mechanisms for fighting plaque are complimentary and additive.
The compositions may also contain conventional ingredients, such as colouring or whitening agents (e.g. titanium dioxide), flavouring and/or sweetening materials, fluorides, such as sodium fluoride, stannous fluoride and sodium monofluorophosphate, and the like. These additional ingredients may each be added to the dentifrice in minimal amounts of up to 5 percent by weight and preferably up to about 1 percent, with respect to compounds which do not contain fluorine, and with respect to compounds which do contain fluorine, amounts to provide about 100 to about 10,000 ppm fluoride, preferably about 500 to about 2,000 ppm, provided that they do not interfere with the antiplaque properties of the finished product.
The composition may also be a liquid, such as mouthrinse which typically contains about 60-99 percent by weight of an aqueous non-toxic lower aliphatic alcohol, preferably having about 5-30 percent by weight of a non-toxic alcohol, such as ethanol, n-propanol or isopropanol, with water and often about 5-35 percent of humectant.
Such oral preparations are typically applied by contacting natural or artificial teeth and gums through brushing with a dentifrice or toothpaste or by contacting teeth and gums by rinsing the oral cavity for about 15-90 seconds, or in the case where lozenges, candy or chewing gum are used by sucking or chewing in the oral cavity, or in the case of a mouthspray by spraying the oral surfaces at least once daily. The invention will now be described with reference to the following examples. It will be appreciated that what follows is by way of example only and that modification of detail may be made without departing from the scope of the invention.
EXPERIMENTAL Activity against selected oral bacteria Antimicrobial activity was tested using axemic cultures of oral bacteria (see Table 1) grown<I>in vitro.</I> All oral isolates were of human origin. The organisms were chosen on the basis of their roles in the development of halitosis and/or periodontal disease (chronic and acute), as documented in the literature. Sunflower oil and olive oil were included as negative controls.
<U>Table 1</U> Identity Bacterial Role in Role in Role in acute Accession halitosis Chronic necrotising Numbers periodontitis' gingivitis' <I>Prevotella oralis</I> NCTC 11459 Yes No No <I>Prevotella</I> NCTC 11321 Yes No No <I>melaninogenica</I> <I>Porphyromonas</I> NCTC 11834 Yes Yes Yes <I>gingivalis</I> <I>Fusobacterium</I> NCTC 10562 Via disease Yes Yes <I>nucleatum</I> <I>Peptostreptococcu</I> NCTC 11460 Yes Yes No <I>s anaerobius</I> <I>Veillonella</I> NCTC1 <B>1809</B> Via disease No No <I>alcalescens</I> Marsh P. and Martin M. (Eds), 1992, Oral Microbiology, 3rd Ed, Chapman and Hall, London. Determination of antimicrobial activity was based on the method of Bennet<I>at al.</I> (Applied Microbiol, 1966, 14, 170-177). Pure cultures of each organism were grown overnight in Iso-Sensitest broth, 37 C (Balchin <I>et al.,</I> Flavour and Fragrance J., 1998, 13, 98-104)). 10 ml of each culture was transferred to 250 ml sterile molten Iso-Sensitest agar at 45 C (Deans and Ritchie, Int. J. Food Microbiol., 1987, 5, 165-180)), mixed using a magnetic stirrer and transferred to sterile 90 mm diameter petri plates. After setting, an agar punch (Pharmacia) was used to produce wells (4 mm diameter) in the agar surface. After use on each plate, the tip of the punch was disinfected using an ethanol wipe. The test oil was filter-sterilised prior to use (Whatman polydisc filter 0.2 gm) and<B>10</B> p1 of oil was pipetted into each well in the agar surface. A maximum of 4 wells were produced on each plate in order to help prevent vapour pressure increases affecting growth. The plates were individually sealed using nonporous plastic tape (Nescofilm) to prevent drying along the edge of the agar. Plates were incubated for 48 h, upright in anaerobic jars at 25 C. Zones of inhibition were measured using vernier callipers (Philip Harris Scientific) to the nearest 0.1 mm through the back of the plate. Duplicate plates were prepared for each sample mix and the experiment was repeated twice.
All culture media were supplied by Oxoid Limited, UK, except where indicated. Sunflower and olive oils were purchased from Sainsbury's Plc. Essential oils were obtained from H. E. Daniel Limited, Billingham, UK.
The results of the experiments are displayed in Table 2. Antibacterial activity was graded as low (0-5.0 mm inhibition zone), medium (5.1-10.0 mm) or high (>10.0 mm). Coriander, cumin, dill weed, lerriongrass and peppermint oils exhibited high antibacterial activity against at least four of the test organisms. Sunflower and olive oil showed little or no effect on bacterial viability.
<U>Example</U> ...
A dog biscuit was prepared according to conventional techniques using 0.1% cumin oil and a biscuit dough comprising the following ingredients: Ground Wheat 30% Oats & Bran 17.5% Grits & Seeds 16.5% Gluten 7.5 Sugar 6% Fat 5% Aromas, Flavours 7.5% Vitamins & Minerals 10% The cumin oil was added to the biscuit dough prior to forming and baking.
Claims (13)
- <U>Claims</U> 1. The use of an effective amount of one or more essential oil(s) selected from coriander, cumin, dill weed, lemongrass and peppermint oil in the manufacture of a composition for the inhibition of pathogenic bacteria present in the oral cavity, the composition being suitable for oral administration.
- 2. A method for the inhibition of pathogenic bacteria present in the oral cavity by the oral administration to a subject in need thereof of a composition comprising an effective amount of one or more essential oil(s) selected from coriander, cumin, dill weed, lemongrass and peppermint oil.
- 3. The use or method according to claim 1 or 2 wherein said use or method is for the maintenance of oral health.
- 4. The use or method according to claim 1, 2 or 3 wherein said use or method is for the inhibition of anaerobic bacteria.
- 5. The use or method of any of claims 1 to 4 wherein the composition is for the treatment of disorders associated with the oral cavity.
- 6. A use or method according to claim 5 wherein said disorders associated with the oral cavity are one or more of gingivitis, periodontal disease and dental caries.
- 7. The use or method of any of claims 1 to 4 wherein the composition is for the treatment of halitosis.
- 8. The use or method of any of claims 1 to 7 wherein the composition is for administration to humans.
- 9. The use or method of any of claims 1 to 7 wherein the composition is for administration to animals.
- 10. A use or method according to claim 9 wherein said composition is a dry or semi moist pet food.
- 11. A use or method according to any preceding claim wherein the essential oil is cumin oil.
- 12. A use or method according to any preceding claim wherein the amount of the or each essential oil is at least about 50 ppm by weight of the composition.
- 13. A use or method according to any preceding claim wherein the amount of the or each essential oil is no more than about 20000 ppm by weight of the composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0000187A GB2359746A (en) | 2000-01-06 | 2000-01-06 | Antibacterial agents |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0000187A GB2359746A (en) | 2000-01-06 | 2000-01-06 | Antibacterial agents |
Publications (2)
Publication Number | Publication Date |
---|---|
GB0000187D0 GB0000187D0 (en) | 2000-03-01 |
GB2359746A true GB2359746A (en) | 2001-09-05 |
Family
ID=9883241
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0000187A Withdrawn GB2359746A (en) | 2000-01-06 | 2000-01-06 | Antibacterial agents |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2359746A (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003092644A2 (en) * | 2002-04-29 | 2003-11-13 | Symrise Gmbh & Co. Kg | Mouth hygiene product containing sugar esters and sugar ethers as antimicrobial active ingredients |
WO2003105794A1 (en) * | 2002-06-18 | 2003-12-24 | Takasago International Corporation | Antibacterial flavor and fragrance composition and halitosis-inhibition flavor and fragrance composition and oral care composition containing the same |
FR2849349A1 (en) * | 2002-12-30 | 2004-07-02 | Virbac | EDIBLE CHEMICAL OBJECT FOR CARNIVOROUS ANIMALS AND METHOD FOR PROVIDING ORAL CAVITY HYGIENE OF SUCH ANIMALS WITH SUCH AN OBJECT |
WO2004073668A1 (en) * | 2003-02-18 | 2004-09-02 | Quest International Services B.V. | Improvements in or relating to flavour compositions |
US6787674B1 (en) | 2003-03-27 | 2004-09-07 | Council Of Scientific And Industrial Research | (+)-1-Bisabolone isolated from cymbopogon flexuosus and antibacterial activity thereof |
WO2004087122A1 (en) * | 2003-03-31 | 2004-10-14 | Council Of Scientific And Industrial Research | (+)-1-bisabolone isolated from cymbopogon flexosus and antibacterial activity thereof |
US7722905B2 (en) | 2003-11-26 | 2010-05-25 | Hill's Pet Nutrition, Inc. | Method to reduce odor of excreta from companion animals |
US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
US11304428B2 (en) | 2015-02-16 | 2022-04-19 | Mars, Incorporated | Interlocking kibble |
US11388914B2 (en) | 2015-04-28 | 2022-07-19 | Mars, Incorporated | Process of preparing a wet pet food, wet pet food produced by the process and uses thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5913712A (en) * | 1982-07-14 | 1984-01-24 | Lion Corp | Composition for oral cavity application |
JPS5929620A (en) * | 1982-08-11 | 1984-02-16 | T Hasegawa Co Ltd | Preventing agent for carious tooth |
EP0473171A1 (en) * | 1990-08-31 | 1992-03-04 | Kao Corporation | Composition for use in oral cavity |
JPH07316064A (en) * | 1993-11-10 | 1995-12-05 | Morishita Jintan Kk | Suppressor for causative of periodontal disease or caries and composition for oral cavity and food containing the same |
WO1997016159A1 (en) * | 1995-10-30 | 1997-05-09 | Warner-Lambert Company | Enhanced anti-inflammatory oral composition containing h2 receptor antagonist and antimicrobial oils |
WO1999027793A2 (en) * | 1997-11-28 | 1999-06-10 | Barrier Biotech Limited | An antimicrobial composition |
-
2000
- 2000-01-06 GB GB0000187A patent/GB2359746A/en not_active Withdrawn
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5913712A (en) * | 1982-07-14 | 1984-01-24 | Lion Corp | Composition for oral cavity application |
JPS5929620A (en) * | 1982-08-11 | 1984-02-16 | T Hasegawa Co Ltd | Preventing agent for carious tooth |
EP0473171A1 (en) * | 1990-08-31 | 1992-03-04 | Kao Corporation | Composition for use in oral cavity |
JPH07316064A (en) * | 1993-11-10 | 1995-12-05 | Morishita Jintan Kk | Suppressor for causative of periodontal disease or caries and composition for oral cavity and food containing the same |
WO1997016159A1 (en) * | 1995-10-30 | 1997-05-09 | Warner-Lambert Company | Enhanced anti-inflammatory oral composition containing h2 receptor antagonist and antimicrobial oils |
WO1999027793A2 (en) * | 1997-11-28 | 1999-06-10 | Barrier Biotech Limited | An antimicrobial composition |
Non-Patent Citations (3)
Title |
---|
WPI Abstract AN 1984-053797 [09] & JP590013712 (LION) * |
WPI Abstract AN 1984-078372 [25] & JP590029620 (HASEGAWA) * |
WPI Abstract AN 1996-055909 [07] & JP070316064 (MORISHITA) * |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003092644A3 (en) * | 2002-04-29 | 2004-04-22 | Symrise Gmbh & Co Kg | Mouth hygiene product containing sugar esters and sugar ethers as antimicrobial active ingredients |
WO2003092644A2 (en) * | 2002-04-29 | 2003-11-13 | Symrise Gmbh & Co. Kg | Mouth hygiene product containing sugar esters and sugar ethers as antimicrobial active ingredients |
CN100508937C (en) * | 2002-06-18 | 2009-07-08 | 高砂香料工业株式会社 | Antibacterial flavor and fragrance composition and halitosis-inhibition flavor and fragrance composition and oral care composition containing the same |
WO2003105794A1 (en) * | 2002-06-18 | 2003-12-24 | Takasago International Corporation | Antibacterial flavor and fragrance composition and halitosis-inhibition flavor and fragrance composition and oral care composition containing the same |
US9681642B2 (en) | 2002-12-30 | 2017-06-20 | Virbac | Edible, chewable object for carnivorous pets and method of controlling the hygiene of the oral cavity of said pets using one such object |
WO2004062358A1 (en) * | 2002-12-30 | 2004-07-29 | Virbac | Edible, chewable object for carnivorous pets and method of controlling the hygiene of the oral cavity of said animals, using one such object |
FR2849349A1 (en) * | 2002-12-30 | 2004-07-02 | Virbac | EDIBLE CHEMICAL OBJECT FOR CARNIVOROUS ANIMALS AND METHOD FOR PROVIDING ORAL CAVITY HYGIENE OF SUCH ANIMALS WITH SUCH AN OBJECT |
WO2004073668A1 (en) * | 2003-02-18 | 2004-09-02 | Quest International Services B.V. | Improvements in or relating to flavour compositions |
JP2006517797A (en) * | 2003-02-18 | 2006-08-03 | クエスト・インターナショナル・サービシーズ・ビー・ブイ | Improved flavor composition |
US6787674B1 (en) | 2003-03-27 | 2004-09-07 | Council Of Scientific And Industrial Research | (+)-1-Bisabolone isolated from cymbopogon flexuosus and antibacterial activity thereof |
WO2004087122A1 (en) * | 2003-03-31 | 2004-10-14 | Council Of Scientific And Industrial Research | (+)-1-bisabolone isolated from cymbopogon flexosus and antibacterial activity thereof |
US7722905B2 (en) | 2003-11-26 | 2010-05-25 | Hill's Pet Nutrition, Inc. | Method to reduce odor of excreta from companion animals |
AU2004294958B2 (en) * | 2003-11-26 | 2011-02-03 | Hill's Pet Nutrition, Inc. | Method to reduce odor of excreta from companion animals |
US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
US11304428B2 (en) | 2015-02-16 | 2022-04-19 | Mars, Incorporated | Interlocking kibble |
US11388914B2 (en) | 2015-04-28 | 2022-07-19 | Mars, Incorporated | Process of preparing a wet pet food, wet pet food produced by the process and uses thereof |
Also Published As
Publication number | Publication date |
---|---|
GB0000187D0 (en) | 2000-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5000940A (en) | Devices, compositions and the like having or containing an inorganic pyrophosphate | |
US6495176B1 (en) | Animal food composition | |
US5015485A (en) | Dog biscuits having a coating containing an inorganic pyrophosphate | |
US5405836A (en) | Pet foods with water-soluble zinc compound coating for controlling malodorous breath | |
US5094870A (en) | Canine biscuits containing an inorganic pyrophosphate | |
US5000943A (en) | Canine biscuits containing an inorganic pyrophosphate | |
CA2332809C (en) | Prevention of dental calculus with polycarboxylic acids | |
US5000973A (en) | Nutritionally-balanced canine biscuits containing an inorganic pyrophosphate | |
JP3877537B2 (en) | Antibacterial agent for oral composition and oral composition containing the same | |
US20060105025A1 (en) | Recovery pet chews | |
JP2005533864A (en) | Composition comprising lactoferrin | |
EP1957032A1 (en) | Vehicles for oral care with magnolia bark extract | |
MX2008000563A (en) | Breath freshening and oral cleansing product comprising a magnolia bark extract and surfactant. | |
GB2359746A (en) | Antibacterial agents | |
JP3614479B2 (en) | Periodontal disease-causing bacteria or caries-causing bacteria inhibitor, oral composition and food containing them | |
US5137717A (en) | Cosmetic preparation having germicidal properties | |
GB1599748A (en) | Compositions containing saccharose-inverting enzyme | |
GB2357967A (en) | Antibacterial agents | |
KR20060024418A (en) | Pet food composition | |
WO2007044819A1 (en) | Prevention of dental plaque and dental calculus in animals | |
JP2010511025A (en) | Oral hygiene composition containing myrtle | |
KR101660467B1 (en) | Oral composition containing fermentative extract of lycii fructus as active ingredient | |
JP4656288B2 (en) | Method for producing pet food for oral care for animals | |
KR20180046247A (en) | Composition for prevention or treatment of oral disease comprising Verbascoside | |
KR20200003604A (en) | Oil composition for preventing and improving periodontal disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |